Open house Arzneimittelrabattverträge Bosutinib, ATC L01EA04
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Bosutinib, ATC L01EA04
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No guaranteed volume or minimum purchase; agreements are non-exclusive and may be superseded by other rebate contracts.
Complex submission requirements: paper copies must be received by specific deadlines, and electronic submissions requir...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Nov 2026
- Provision of Bosutinib (ATC L01EA04) under non-exclusive rebate agreements with AOK Bayern.
- Contracts are open to all interested pharmaceutical companies meeting eligibility criteria.
Show full summary
Open-house model for non-exclusive drug rebate agreements for Bosutinib (ATC L01EA04) with AOK Bayern. All interested pharmaceutical companies meeting eligibility can join. No competitive selection, no estimated value disclosed. Contract duration December 2024 to November 2026, with flexible entry until October 2026.
Risks
No guaranteed volume or minimum purchase; agreements are non-exclusive and may be superseded by other rebate contracts.
Complex submission requirements: paper copies must be received by specific deadlines, and electronic submissions requir...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company.
Administrative
- Submit signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Submit signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.
Requirements may be incomplete.
Buyer
Name
AOK Bayern - Die Gesundheitskasse
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Bosutinib, ATC L01EA04
Non-exclusive rebate agreements for Bosutinib. All eligible pharmaceutical companies can enter into identical, non-negotiable contracts. No competition, open to all who meet eligibility.
Location
Duration
Category
Deadline
Award details
Selection criteria
Show original TED data
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Oct 2024
- Notice type
- Contract notice — standard
- Languages
- German
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 628220-2024
Documents (2)
Similar tenders
Germany – Heating, ventilation and air-conditioning installation work – VE BT11-4310-01 Lüftung
Belgium – Electrical supplies and accessories – Raamovereenkomst voor het leveren van verlichtingsarmaturen
Czechia – Vertical-spindle machining centre – Pořízení 5-osého CNC centra
Poland – Miscellaneous medical devices and products – Zakup i dostawa sprzętu i wyposażenia dla Zakładu Opiekuńczo-Leczniczego
Sweden – Water plumbing work – Ramavtal för entreprenader för schaktfri ledningsrenovering med flexibla foder
Poland – Miscellaneous evaluation or testing instruments – Zakup i dostawa do laboratoriów GIOŚ wyposażenia do zatężania ekstraktów chromatograficznych
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No guaranteed volume or minimum purchase; agreements are non-exclusive and may be superseded by other rebate contracts.
Complex submission requirements: paper copies must be received by specific deadlines, and electronic submissions requir...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications